Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SLC22A1 Antikörper

SLC22A1 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 2C5 unconjugated
Produktnummer ABIN969400
  • Target Alle SLC22A1 Antikörper anzeigen
    SLC22A1 (Solute Carrier Family 22 (Organic Cation Transporter), Member 1 (SLC22A1))
    Reaktivität
    • 47
    • 9
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 40
    • 8
    • 1
    Maus
    Klonalität
    • 41
    • 8
    Monoklonal
    Konjugat
    • 22
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser SLC22A1 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 23
    • 17
    • 2
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human SLC22A1 expressed in E. coli.
    Klon
    2C5
    Isotyp
    IgG1
    Top Product
    Discover our top product SLC22A1 Primärantikörper
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, FCM: 1:200 - 1:400
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Zach, Krieger, Foedermayr, Zellhofer, Lutz: "OCT1 (SLC22A1) R61C polymorphism and response to imatinib treatment in chronic myeloid leukemia patients." in: Leukemia & lymphoma, Vol. 49, Issue 11, pp. 2222-3, (2008) (PubMed).

    Hirayama, Watanabe, Nakashima, Nanbu, Hamada, Kuniyasu, Nakayama, Kawaguchi, Saito: "Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells." in: Pharmaceutical research, Vol. 25, Issue 4, pp. 827-35, (2008) (PubMed).

    Giannoudis, Davies, Lucas, Harris, Pirmohamed, Clark: "Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia." in: Blood, Vol. 112, Issue 8, pp. 3348-54, (2008) (PubMed).

  • Target
    SLC22A1 (Solute Carrier Family 22 (Organic Cation Transporter), Member 1 (SLC22A1))
    Andere Bezeichnung
    SLC22A1 (SLC22A1 Produkte)
    Synonyme
    SLC22A1 antikoerper, OCT1 antikoerper, HOCT1 antikoerper, oct1_cds antikoerper, Lx1 antikoerper, Oct1 antikoerper, Orct antikoerper, Orct1 antikoerper, Roct1 antikoerper, SLC22A2 antikoerper, solute carrier family 22 member 1 antikoerper, solute carrier family 22 (organic cation transporter), member 1 antikoerper, solute carrier family 22 member 2-like antikoerper, SLC22A1 antikoerper, Slc22a1 antikoerper, LOC421584 antikoerper
    Hintergrund

    Description: Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. This gene is one of three similar cation transporter genes located in a cluster on chromosome 6. The encoded protein contains twelve putative transmembrane domains and is a plasma integral membrane protein. Tissue specificity: Widely expressed with high level in liver.

    Aliases: OCT1, HOCT1, oct1_cds, SLC22A1

    Molekulargewicht
    61.2 kDa
    Gen-ID
    6580
    HGNC
    6580
    Pathways
    Hormone Transport
Sie sind hier:
Kundenservice